TWO · Healthcare

Greenyn Biotechnology Co., Ltd (6846)

Biotechnology

Greenyn Biotechnology Co., Ltd (6846) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6846

P/E ratio

25.00

Greenyn Biotechnology Co., Ltd (6846) — FAQ

What is 6846's P/E ratio?

The price-to-earnings (P/E) ratio for Greenyn Biotechnology Co., Ltd (6846) is 25.00 (data as of 2026-05-23).

Does Greenyn Biotechnology Co., Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Greenyn Biotechnology Co., Ltd (6846). Check the MyAverix Finance app for the latest dividend data.

What sector is Greenyn Biotechnology Co., Ltd in?

Greenyn Biotechnology Co., Ltd (6846) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6846 listed on?

6846 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)